How stable are Transferability Metrics evaluations?

Transferability metrics is a maturing field with increasing interest, which aims at providing heuristics for selecting the most suitable source models to transfer to a given target dataset, without fine-tuning them all. However, existing works rely on custom experimental setups which differ across papers, leading to inconsistent conclusions about which transferability metrics work best. In this paper we conduct a large-scale study by systematically constructing a broad range of 715k experimental setup variations. We discover that even small variations to an experimental setup lead to different conclusions about the superiority of a transferability metric over another. Then we propose better evaluations by aggregating across many experiments, enabling to reach more stable conclusions. As a result, we reveal the superiority of LogME at selecting good source datasets to transfer from in a semantic segmentation scenario, NLEEP at selecting good source architectures in an image classification scenario, and GBC at determining which target task benefits most from a given source model. Yet, no single transferability metric works best in all scenarios

GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers

Background: Increased glycolytic activity is a hallmark of cancer, allowing staging and restaging with 18F-fluorodeoxyglucose-positron-emission-tomography (PET). Since interim-PET is an important prognostic tool in Hodgkin lymphoma (HL), the aim of this study was to investigate the expression of proteins involved in the regulation of glucose metabolism in the different HL subtypes and their impact on clinical outcome. Methods: Lymph node biopsies from 54 HL cases and reactive lymphoid tissue were stained for glucose transporter 1 (GLUT1), lactate dehydrogenase A (LDHA) and lactate exporter proteins MCT1 and MCT4. In a second series, samples from additional 153 HL cases with available clinical data were stained for GLUT1 and LDHA. Results: Membrane bound GLUT1 expression was frequently observed in the tumor cells of HL (49% of all cases) but showed a broad variety between the different Hodgkin lymphoma subtypes: Nodular sclerosing HL subtype displayed a membrane bound GLUT1 expression in the Hodgkin-and Reed-Sternberg cells in 56% of the cases. However, membrane bound GLUT1 expression was more rarely observed in tumor cells of lymphocyte rich classical HL subtype (30%) or nodular lymphocyte predominant HL subtype (15%). Interestingly, in both of these lymphocyte rich HL subtypes as well as in progressively transformed germinal centers, reactive B cells displayed strong expression of GLUT1. LDHA, acting downstream of glycolysis, was also expressed in 44% of all cases. We evaluated the prognostic value of different GLUT1 and LDHA expression patterns; however, no significant differences in progression free or overall survival were found between patients exhibiting different GLUT1 or LDHA expression patterns. There was no correlation between GLUT1 expression in HRS cells and PET standard uptake values. Conclusions: In a large number of cases, HRS cells in classical HL express high levels of GLUT1 and LDHA indicating glycolytic activity in the tumor cells. Although interim-PET is an important prognostic tool, a predictive value of GLUT1 or LDHA staining of the primary diagnostic biopsy could not be demonstrated. However, we observed GLUT1 expression in progressively transformed germinal centers and hyperplastic follicles, explaining false positive results in PET. Therefore, PET findings suggestive of HL relapse should always be confirmed by histology

Process mining meets model learning: Discovering deterministic finite state automata from event logs for business process analysis

Within the process mining field, Deterministic Finite State Automata (DFAs) are largely employed as foundation mechanisms to perform formal reasoning tasks over the information contained in the event logs, such as conformance checking, compliance monitoring and cross-organization process analysis, just to name a few. To support the above use cases, in this paper, we investigate how to leverage Model Learning (ML) algorithms for the automated discovery of DFAs from event logs. DFAs can be used as a fundamental building block to support not only the development of process analysis techniques, but also the implementation of instruments to support other phases of the Business Process Management (BPM) lifecycle such as business process design and enactment. The quality of the discovered DFAs is assessed wrt customized definitions of fitness, precision, generalization, and a standard notion of DFA simplicity. Finally, we use these metrics to benchmark ML algorithms against real-life and synthetically generated datasets, with the aim of studying their performance and investigate their suitability to be used for the development of BPM tools

Preliminary Validation of a Low-Cost Motion Analysis System Based on RGB Cameras to Support the Evaluation of Postural Risk Assessment

This paper introduces a low-cost and low computational marker-less motion capture system based on the acquisition of frame images through standard RGB cameras. It exploits the open-source deep learning model CMU, from the tf-pose-estimation project. Its numerical accuracy and its usefulness for ergonomic assessment are evaluated by a proper experiment, designed and performed to: (1) compare the data provided by it with those collected from a motion capture golden standard system; (2) compare the RULA scores obtained with data provided by it with those obtained with data provided by the Vicon Nexus system and those estimated through video analysis, by a team of three expert ergonomists. Tests have been conducted in standardized laboratory conditions and involved a total of six subjects. Results suggest that the proposed system can predict angles with good consistency and give evidence about the tool’s usefulness for ergonomist

Supporting Governance in Healthcare Through Process Mining: A Case Study

Healthcare organizations are under increasing pressure to improve productivity, gain competitive advantage and reduce costs. In many cases, despite management already gained some kind of qualitative intuition about inefciencies and possible bottlenecks related to the enactment of patients' careows, it does not have the right tools to extract knowledge from available data and make decisions based on a quantitative analysis. To tackle this issue, starting from a real case study conducted in San Carlo di Nancy hospital in Rome (Italy), this article presents the results of a process mining project in the healthcare domain. Process mining techniques are here used to infer meaningful knowledge about the patient careflows from raw event logs consisting of clinical data stored by the hospital information systems. These event logs are analyzed using the ProM framework from three different perspectives: the control flow perspective, the organizational perspective and the performance perspective. The results on the proposed case study show that process mining provided useful insights for the governance of the hospital. In particular, we were able to provide answers to the management of the hospital concerning the value of last investments, and the temporal distribution of abandonments from emergency room and exams without reservation

Brain2Music: Reconstructing Music from Human Brain Activity

The process of reconstructing experiences from human brain activity offers a unique lens into how the brain interprets and represents the world. In this paper, we introduce a method for reconstructing music from brain activity, captured using functional magnetic resonance imaging (fMRI). Our approach uses either music retrieval or the MusicLM music generation model conditioned on embeddings derived from fMRI data. The generated music resembles the musical stimuli that human subjects experienced, with respect to semantic properties like genre, instrumentation, and mood. We investigate the relationship between different components of MusicLM and brain activity through a voxel-wise encoding modeling analysis. Furthermore, we discuss which brain regions represent information derived from purely textual descriptions of music stimuli. We provide supplementary material including examples of the reconstructed music at https://google-research.github.io/seanet/brain2musicComment: Preprint; 21 pages; supplementary material: https://google-research.github.io/seanet/brain2musi

Bitter tastants and artificial sweeteners activate a subset of epithelial cells in acute tissue slices of the rat trachea

Bitter and sweet receptors (T2Rs and T1Rs) are expressed in many extra-oral tissues including upper and lower airways. To investigate if bitter tastants and artificial sweeteners could activate physiological responses in tracheal epithelial cells we performed confocal Ca2+ imaging recordings on acute tracheal slices. We stimulated the cells with denatonium benzoate, a T2R agonist, and with the artificial sweeteners sucralose, saccharin and acesulfame-K. To test cell viability we measured responses to ATP. We found that 39% of the epithelial cells responding to ATP also responded to bitter stimulation with denatonium benzoate. Moreover, artificial sweeteners activated different percentages of the cells, ranging from 5% for sucralose to 26% for saccharin, and 27% for acesulfame-K. By using carbenoxolone, a gap junction blocker, we excluded that responses were mainly mediated by Ca2+ waves through cell-to-cell junctions. Pharmacological experiments showed that both denatonium and artificial sweeteners induced a PLC-mediated release of Ca2+ from internal stores. In addition, bitter tastants and artificial sweeteners activated a partially overlapping subpopulation of tracheal epithelial cells. Our results provide new evidence that a subset of ATP-responsive tracheal epithelial cells from rat are activated by both bitter tastants and artificial sweeteners

In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia

Background: Although progress in children, in adults, ALL still carries a dismal outcome. Here, we explored the in vitro and in vivo activity of PF-00477736 (Pfizer), a potent, selective ATP-competitive small-molecule inhibitor of checkpoint kinase 1 (Chk1) and with lower efficacy of checkpoint kinase 2 (Chk2). Methods: The effectiveness of PF-00477736 as single agent in B-/T-ALL was evaluated in vitro and in vivo studies as a single agent. The efficacy of the compound in terms of cytotoxicity, induction of apoptosis, and changes in gene and protein expression was assessed using different B-/T-ALL cell lines. Finally, the action of PF-00477736 was assessed in vivo using leukemic mouse generated by a single administration of the tumorigenic agent n-ethyl-n-nitrosourea. Results: Chk1 and Chk2 are overexpressed concomitant with the presence of genetic damage as suggested by the nuclear labeling for \u3b3-H2A.X (Ser139) in 68 % of ALL patients. In human B-and T-ALL cell lines, inhibition of Chk1/2 as a single treatment strategy efficiently triggered the Chk1-Cdc25-Cdc2 pathway resulting in a dose-and time-dependent cytotoxicity, induction of apoptosis, and increased DNA damage. Moreover, treatment with PF-00477736 showed efficacy ex vivo in primary leukemic blasts separated from 14 adult ALL patients and in vivo in mice transplanted with T-ALL, arguing in favor of its future clinical evaluation in leukemia. Conclusions: In vitro, ex vivo, and in vivo results support the inhibition of Chk1 as a new therapeutic strategy in acute lymphoblastic leukemia, and they provide a strong rationale for its future clinical investigation

Measurement of quarkonium production at forward rapidity in pp collisions at √s=7 TeV

The inclusive production cross sections at forward rapidity of J/ψ , ψ(2S) , Υ (1S) and Υ (2S) are measured in pp collisions at s√=7 TeV with the ALICE detector at the LHC. The analysis is based on a data sample corresponding to an integrated luminosity of 1.35 pb‾¹ . Quarkonia are reconstructed in the dimuon-decay channel and the signal yields are evaluated by fitting the μ+μ− invariant mass distributions. The differential production cross sections are measured as a function of the transverse momentum pT and rapidity y , over the ranges 0<pT<20 GeV/c for J/ψ , 0<pT<12 GeV/c for all other resonances and for \(2.5 . The measured cross sections integrated over pT and y , and assuming unpolarized quarkonia, are: σJ/ψ=6.69±0.04±0.63 μ b, σψ(2S)=1.13±0.07±0.19 μ b, σΥ(1S)=54.2±5.0±6.7 nb and σΥ(2S)=18.4±3.7±2.9 nb, where the first uncertainty is statistical and the second one is systematic. The results are compared to measurements performed by other LHC experiments and to theoretical models